gabe@gabegold.com
Date: Sun, 10 Feb 2019 15:45:03 -0500
The Food and Drug Administration (FDA) wants to transform the way it tracks
and traces medicines in an effort to protect supply chain security. The road
to achieving that goal runs straight through improved technology, the agency
writes in a regulatory notice. Commissioner Scott Gottlieb even busted out
the "B" word... "We're invested in exploring new ways to improve
traceability, in some cases using the same technologies that can enhance
drug supply chain security, like the use of blockchain. To advance these
efforts, the FDA recently recruited Frank Yiannas, an expert on the use of
traceability technologies in global food supply chains. He'll be working
closely with me on ways for the FDA to facilitate the expansion of such
methods, such as blockchain technology, to further strengthen the U.S. food
supply," he wrote in a statement. /(FDA
<https://click.email.fortune.com/%3Fqs%3D51a73d1016def0c54ce8c32d0d2ae31fc729c67c51791aaed3df61eb3995b42696af864bd63fdc5f8fb24799ea342d226380f6ed4edcde37
"Using new innovations..." -- as opposed to old innovations, I guess.
Blockchain, magic as always:
``For the drug track-and-trace system, our goals are to fully secure electronic product tracing, which provides a step-by-step account of where a drug product has been located and who has handled it; establish a more robust product verification to ensure that a drug product is legitimate and unaltered; and to make sure that any party involved in handling drugs in the supply chain must have the ability to spot and quarantine and investigate any suspect drug. We're committed to staying at the forefront of new and emerging technologies and how they might be used to create safer, smarter and more trusted supply chains to better protect consumer safety and ensure the integrity of the high quality of products they deserve.''